Mental illness is a matter of willpower and attitude

The claim

Mental illness is largely a matter of attitude, resilience, and effort. The prevalence of depression and anxiety reflects cultural permissiveness and over-medicalization. People in previous generations handled hard circumstances without labeling normal sadness as illness. True resilience means working through adversity without pharmaceutical intervention.

The mechanism

Mental health conditions have established neurobiological bases that have been documented across multiple research methodologies — not just clinical observation, but brain imaging, genetic studies, and pharmacological intervention trials. The neurobiology is not the whole story (social and environmental factors are also causal), but it definitively refutes the “choice” framing.

Neurobiological evidence: Major depressive disorder is associated with measurable structural and functional brain changes. Schmaal et al.’s 2016 ENIGMA consortium meta-analysis (Molecular Psychiatry, 21, 806–812; doi:10.1038/mp.2015.69) found consistent hippocampal volume reductions in MDD across 1,728 MDD patients and 7,199 controls from 15 research samples worldwide. HPA axis dysregulation (elevated cortisol, altered glucocorticoid receptor function) is reliably found in patients with major depression. These are not self-reports; they are biological measurements.

The inequality correlation: Richard Wilkinson and Kate Pickett’s The Spirit Level (2009) assembled OECD mental illness prevalence data across 11 wealthy nations. The correlation between income inequality (Gini coefficient) and mental illness rates: r = 0.73. This is not explained by absolute income — Japan and Sweden have lower mental illness rates despite differing absolute wealth levels. The proposed mechanism: higher inequality increases status anxiety, social comparison stress, and chronic low-status threat responses. This is consistent with evolutionary and social-psychological theories of chronic social subordination. Countries with more compressed income distributions show lower mental illness rates.

The trajectory in the US: The suicide rate in the US rose from 10.5/100,000 in 2000 to 14.2/100,000 in 2021 — a 35% increase over 21 years (CDC WISQARS). The increase cannot be explained by diagnostic changes (suicide is definitional) or increased self-report bias. The increase was sharpest among working-age adults (25–64), particularly those without bachelor’s degrees — a demographic that experienced the most acute decline in economic security, union membership, and stable employment during this period. Anne Case and Angus Deaton’s research on “deaths of despair” (Mortality and Morbidity in the 21st Century, Brookings 2017) documented that this excess mortality — overdoses, alcohol-related liver disease, and suicide — was concentrated in whites without college degrees who experienced deindustrialization. It is not a willpower story; it tracks economic catastrophe precisely.

Access to care as a structural variable: The US has a severe shortage of psychiatrists — 14.6 per 100,000 population (2021 HRSA data), compared to 27.0 in Germany and 25.4 in France. Rural areas have critical shortages: 65% of US mental health professional shortage areas are rural. The wait time for an outpatient psychiatric appointment averages 25 days nationally; in many markets, it exceeds 3 months. Psychotherapy is similarly inaccessible: Medicare covers it, but many therapists do not accept Medicare reimbursement rates. The ACA required mental health parity — equal coverage of mental and physical conditions — but enforcement has been weak.

Who benefits

Insurance companies that impose visit limits (e.g., 6 psychotherapy sessions/year versus unlimited specialist visits for physical conditions) reduce claims costs. Employer self-insurance plans have the same incentive and are regulated by ERISA, which preempts state mental health parity laws. A 2023 NAMI survey found that 92% of respondents in states with documented parity violations experienced at least one access problem due to insurer behavior — prior authorization denials, narrow networks without in-network providers, or inadequate reimbursement rates that drive providers out of network.

The “willpower” framing also serves employers who deny accommodation for mental health conditions under the ADA. Psychiatric disabilities are the second most common ADA accommodation request; denials citing “personal attitude” are documented in EEOC enforcement files.

The data

SAMHSA’s National Survey on Drug Use and Health (NSDUH) provides annual prevalence estimates. The 2022 NSDUH (published November 2023) found:

• 59.3 million adults (23.1%) had any mental illness in the past year
• 21.5 million adults (8.3%) had a major depressive episode
• 48.7 million adults (18.9%) had a substance use disorder
• 26.1 million adults (10.1%) received mental health treatment, meaning the treatment gap (those with mental illness who received no treatment) was approximately 33 million people

The treatment gap is not explained by preference — surveys consistently find that cost and access are the primary barriers. A 2022 KFF Health Tracking Poll found that among adults who needed mental health care but did not receive it, 42% cited cost, 25% cited not knowing where to go, and 14% cited not being able to get an appointment.

Cross-national mental health outcome data:

Sources: WHO Global Health Observatory; OECD Health at a Glance; NIMH; HRSA Shortage Areas.

Note: Japan’s high suicide rate with low depression prevalence likely reflects under-reporting of depression (cultural stigma) and different etiological pathways. The comparison to Germanic and Nordic countries, with lower inequality and better access, is more direct.

Comparators

Iceland, despite its winter darkness and geographic isolation (risk factors for seasonal affective disorder), has substantially lower clinical depression rates than the US. Proposed mechanisms: tight-knit community social ties, universal healthcare access with well-reimbursed psychotherapy, and low income inequality (Gini ~0.28 vs. US ~0.39). Iceland’s OECD-measured depression prevalence is approximately 3.5%.

Germany’s statutory health insurance (SHI) covers psychotherapy up to 80+ sessions with minimal co-pay, following diagnostic assessment. Wait times for therapy are typically 4–8 weeks — less than half the US average. Germany’s suicide rate (9.4) is one-third lower than the US (14.2), despite similar absolute wealth levels.

The counter

The over-medicalization critique has partial validity at the margins: the DSM’s expansion from DSM-III (1980) to DSM-5 (2013) added diagnostic categories (e.g., “disruptive mood dysregulation disorder”) that some psychiatrists view as medicalizing normal emotional states. Pharmaceutical marketing has influenced both diagnostic rates and treatment choices — an NEJM meta-analysis (Kirsch et al., 2008) found antidepressant effects for mild-to-moderate depression were largely within the placebo margin, though effects for severe depression were substantial. These are genuine debates within the profession. They do not support the conclusion that mental illness is primarily willpower. The question is not whether medications are the right first-line treatment for every presentation — it is whether the underlying conditions are real, neurobiologically grounded, and responsive to structural interventions. The evidence says yes on all three counts.

References

Case, A., & Deaton, A. (2017). Mortality and morbidity in the 21st century. Brookings Papers on Economic Activity, Spring 2017, 397–476. https://doi.org/10.1353/eca.2017.0005

Centers for Disease Control and Prevention. (2023). Web-based injury statistics query and reporting system (WISQARS). National Center for Injury Prevention and Control. https://www.cdc.gov/injury/wisqars/

Health Resources and Services Administration. (2021). Behavioral health workforce projections, 2016–2030. U.S. Department of Health and Human Services. https://bhw.hrsa.gov/data-research/projecting-health-workforce-supply-demand

National Alliance on Mental Illness. (2023). Parity compliance: A review of state insurance laws and enforcement activities. NAMI. https://www.nami.org/Advocacy/Policy-Priorities/Access-to-Care/Insurance-Parity

OECD. (2023). Health at a glance 2023. OECD Publishing. https://doi.org/10.1787/7a7afb35-en

Schmaal, L., Veltman, D. J., van Erp, T. G. M., Sämann, P. G., Frodl, T., Jahanshad, N., Loehrer, E., Tiemeier, H., Hofman, A., Niessen, W. J., Vernooij, M. W., Ikram, M. A., Wittfeld, K., Grabe, H. J., Block, A., Hegenscheid, K., Völzke, H., Hoehn, D., Czisch, M., … Hibar, D. P. (2016). Subcortical brain alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group. Molecular Psychiatry, 21(6), 806–812. https://doi.org/10.1038/mp.2015.69

Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022 national survey on drug use and health (HHS Publication No. PEP23-07-01-006). SAMHSA. https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report

Wilkinson, R., & Pickett, K. (2009). The spirit level: Why more equal societies almost always do better. Allen Lane.